Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  American Journal of Cardiology

• Publication date

  2012-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.amjcard.2011.09.037PMID 22176999
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Progress towards a National Cardiac Procedure Database--development of the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and Melbourne Interventional Group (MIG) registries.

  2011cited by this paper
• Quality control activities associated with registries in interventional cardiology and surgery.

  2011cited by this paper
• Predictive Factors and Impact of No Reflow After Primary Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

  2010cited by this paper
• Myocardial no-reflow in humans.

  2009cited by this paper
• The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents.

  2009cited by this paper
• Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study.

  2008cited by this paper
• Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden.

  2007cited by this paper
• The foundation and launch of the Melbourne Interventional Group: a collaborative interventional cardiology project.

  2006cited by this paper
• Impact of reversibility of no reflow phenomenon on 30-day mortality following percutaneous revascularization for acute myocardial infarction-insights from a 1,328 patient registry.

  2005cited by this paper
• Coronary and myocardial angiography: angiographic assessment of both epicardial and myocardial perfusion.

  2004cited by this paper
• Usefulness of myocardial blush grade early and late after primary coronary angioplasty for acute myocardial infarction in predicting left ventricular function.

  2003cited by this paper
• Temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation

  2003cited by this paper
• Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation.

  2003cited by this paper
• No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention.

  2003cited by this paper
• Prognostic significance of transient no-reflow during primary percutaneous coronary intervention for ST-elevation acute myocardial infarction.

  2003cited by this paper
• Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon.

  2002cited by this paper
• Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts

  2002cited by this paper
• The coronary no-reflow phenomenon: a review of mechanisms and therapies.

  2001cited by this paper
• Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction.

  2001cited by this paper
• Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction.

  2000cited by this paper
• Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions.

  2000cited by this paper
• Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial.

  2000cited by this paper
• Retrieval and analysis of particulate debris after saphenous vein graft intervention.

  1999cited by this paper
• Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction.

  1998cited by this paper
• Features and outcome of no-reflow after percutaneous coronary intervention.

  1995cited by this paper
• Incidence and treatment of 'no-reflow' after percutaneous coronary intervention.

  1994cited by this paper
• Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial.

  1989cited by this paper

• The Naples Prognostic Score May Predict No Reflow in Patients Undergoing Percutaneous Coronary Intervention for Saphenous Vein Graft Stenosis

  2026cites this paper
• Sex-based Differences in Complications Following Percutaneous Coronary Interventions

  2025cites this paper
• IVUS derived plaque characteristics and outcomes in patients with acute coronary syndrome undergoing percutaneous intervention

  2025cites this paper
• No-Reflow Prediction in Acute Coronary Syndrome During Percutaneous Coronary Intervention: The NORPACS Risk Score

  2024cites this paper
• Association between lipid-rich plaques and thrombus formation after excimer laser coronary angioplasty in in-stent restenosis and de novo lesions

  2024cites this paper
• Long-term outcome and prognostic value of angiographic slow/no-reflow phenomenon after emergency percutaneous coronary intervention for ST-elevation myocardial infarction

  2024cites this paper
• Intracoronary Near-Infrared Spectroscopy to Predict No-Reflow Phenomenon During Percutaneous Coronary Intervention in Acute Coronary Syndrome.

  2024cites this paper
• Cardioprotective Effects of Nano-Piperine Against Cypermethrin Toxicity Through Oxidative Stress, Histopathological and Immunohistochemical Studies in Male Wistar Rats

  2023cites this paper
• Assessment of systemic immune-inflammation index as an independent surrogate biomarker of no-reflow phenomenon in acute coronary syndrome patients with coronary artery bypass grafting undergoing percutaneous coronary intervention of saphenous vein graft.

  2023cites this paper
• Hepatoprotective Effect of Curcumin Nano-Lipid Carrier against Cypermethrin Toxicity by Countering the Oxidative, Inflammatory, and Apoptotic Changes in Wistar Rats

  2023cites this paper
• No-reflow phenomenon and triglyceride-glucose index in acute myocardial infarction

  2023cites this paper
• Optical Coherence Tomography Assessment of Coronary Lesions Associated With Microvascular Dysfunction in ST-Segment Elevation Myocardial Infarction.

  2023cites this paper
• Comparison of the efficacy of excimer laser coronary angioplasty for ST-segment elevation myocardial infarction with onset-to-balloon time

  2023cites this paper
• Intravascular ultrasound-factors associated with slow flow following rotational atherectomy in heavily calcified coronary artery

  2022cites this paper
• Relationship between attenuated plaque identified by intravascular ultrasound and thrombus formation after excimer laser coronary angioplasty.

  2022cites this paper
• O Escore Gensini e a Carga Trombótica Adicionam Valor Preditivo ao Escore SYNTAX na Detecção de No-Reflow após Infarto do Miocárdio

  2021cites this paper
• Small lipid core burden index in patients with stable angina pectoris is also associated with microvascular dysfunction: Insights from intracoronary electrocardiogram

  2021cites this paper
• Gensini Score and Thrombus Burden Add Predictive Value to the SYNTAX Score in Detecting No-Reflow after Myocardial Infarction

  2021cites this paper
• Serum Triglycerides Fasting Glycemic Product Index Predict No-Reflow Phenomenon in Patients with Actue Myocardial Infarction Undergoing Primary Coronary Intervention

  2021cites this paper
• Mechanism and Potential Treatment of the 'No Reflow' Phenomenon After Acute Myocardial Infarction: Role of Pericytes and GPR39.

  2021cites this paper
• Inflammation during Percutaneous Coronary Intervention—Prognostic Value, Mechanisms and Therapeutic Targets

  2021cites this paper
• Intracoronary Thrombolysis in Patients With ST-Segment Elevation Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials

  2021cites this paper
• Clinical outcomes following ST‐elevation myocardial infarction secondary to stent thrombosis treated by percutaneous coronary intervention

  2020influential citation
• The protective effect of piperine against isoproterenol-induced inflammation in experimental models of myocardial toxicity.

  2020cites this paper
• Effect of nicorandil treatment adjunctive to percutaneous coronary intervention in patients with acute myocardial infarction: a systematic review and meta-analysis

  2020cites this paper
• Effect of Endoplasmic Reticulum Stress on Endothelial Ischemia-Reperfusion Injury in Humans.

  2020cites this paper
• No-reflow phenomenon and comparison to the normal-flow population postprimary percutaneous coronary intervention for ST elevation myocardial infarction: case–control study (NORM PPCI)

  2020cites this paper
• Intracoronary application of nicorandil regulates the inflammatory response induced by percutaneous coronary intervention

  2020cites this paper
• Complete versus culprit only revascularisation in patients with cardiogenic shock complicating acute myocardial infarction: Incidence and outcomes from The London Heart Attack Group.

  2020cites this paper
• Long-term outcomes in men and women with ST-segment elevation myocardial infarction and incomplete reperfusion after a primary percutaneous coronary intervention: a 2-year follow-up

  2019cites this paper
• The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

  2019cites this paper
• Effects of Intracoronary Nicorandil on Myocardial Microcirculation and Clinical Outcomes in Patients with Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials

  2019cites this paper
• Predictors of Coronary Artery Disease Progression among High-risk Patients with Recurrent Symptoms

  2018cites this paper
• Relation of hemoglobin level to no-reflow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention

  2018cites this paper
• A Randomized Study of Distal Filter Protection Versus Conventional Treatment During Percutaneous Coronary Intervention in Patients With Attenuated Plaque Identified by Intravascular Ultrasound.

  2018cites this paper
• The relationship between low thiol levels and major adverse cardiovascular events after primary percutaneous coronary intervention in patients with STEMI STEMI hastalarında primer perkütan koroner girişim sonrası düşük tiyol seviyeleri ve

  2018cites this paper
• The clinical significance of echo-attenuated plaque in stable angina pectoris compared with acute coronary syndromes: A combined intravascular ultrasound and optical coherence tomography study.

  2018cites this paper
• Contemporary trends in cardiogenic shock: Incidence, intra-aortic balloon pump utilisation and outcomes from the London Heart Attack Group

  2018cites this paper
• Long-term clinical outcomes of transient and persistent no-reflow following percutaneous coronary intervention (PCI): a multicentre Australian registry.

  2018cites this paper
• Passive heat therapy protects against endothelial cell hypoxia‐reoxygenation via effects of elevations in temperature and circulating factors

  2018cites this paper
• Correlates of the “No-Reflow” or “Slow-Flow” Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention

  2018cites this paper
• Acute treatment with copoazú fermented extract ameliorates myocardial ischemia-reperfusion injury via eNOS activation

  2017cites this paper
• Adiponectin improves coronary no-reflow injury by protecting the endothelium in rats with type 2 diabetes mellitus

  2017cites this paper
• Identification of High-Risk Patients After ST-Segment–Elevation Myocardial Infarction: Comparison Between Angiographic and Magnetic Resonance Parameters

  2017cites this paper
• Paeonol Protects Rat Heart by Improving Regional Blood Perfusion during No-Reflow

  2016cites this paper
• Repeated ischaemic preconditioning: a novel therapeutic intervention and potential underlying mechanisms

  2016influential citation
• Clinical significance of no-reflow in different stages of primary angioplasty among patients with acute myocardial infarctions

  2016cites this paper
• Ischaemic preconditioning in exercise and disease: One size fits all?

  2016cites this paper
• Long-Term Clinical Outcomes of Transient and Persistent No Reflow Phenomena following Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction

  2016cites this paper
• Tirofiban induces vasorelaxation of the coronary artery via an endothelium-dependent NO-cGMP signaling by activating the PI3K/Akt/eNOS pathway.

  2016cites this paper
• [Nonplatelet Effects of Ticagrelor].

  2016cites this paper
• Acute hot water immersion is protective against impaired vascular function following forearm ischemia-reperfusion in young healthy humans.

  2016cites this paper
• The Human Microcirculation: Regulation of Flow and Beyond.

  2016cites this paper
• A simple and rapid method for identification of lesions at high risk for the no-reflow phenomenon immediately before elective coronary stent implantation

  2016cites this paper
• Effect of inflammatory factor‐induced cyclo‐oxygenase expression on the development of reperfusion‐related no‐reflow phenomenon in acute myocardial infarction

  2015cites this paper
• Intracoronary administration of anisodamine and nicorandil in individuals undergoing primary percutaneous coronary intervention for acute inferior myocardial infarction: A randomized factorial trial.

  2015cites this paper
• Predictors and outcome of no-reflow post primary percutaneous coronary intervention for ST elevation myocardial infarction

  2015cites this paper
• Impact of thin-cap fibroatheroma on predicting deteriorated coronary flow during interventional procedures in acute as well as stable coronary syndromes: insights from optical coherence tomography analysis

  2015cites this paper
• Impact of transient or persistent slow flow and adjunctive distal protection on mortality in ST-segment elevation myocardial infarction

  2015cites this paper
• Growth differentiation factor 15 may protect the myocardium from no-reflow by inhibiting the inflammatory-like response that predominantly involves neutrophil infiltration

  2015cites this paper
• Distal coronary embolization following acute myocardial infarction increases early infarct size and late left ventricular wall thinning in a porcine model

  2015cites this paper
• The relationship between Gensini score and ST-segment resolution in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

  2014cites this paper
• Transient no reflow following primary percutaneous coronary intervention

  2014cites this paper
• The "no reflow" phenomenon following acute myocardial infarction: mechanisms and treatment options.

  2014cites this paper
• eview he “ no reflow ” phenomenon following acute myocardial infarction : echanisms and treatment options

  2014cites this paper
• Lessons from primary PCI practice for the next decade

  2014cites this paper
• Aging attenuates the protective effect of ischemic preconditioning against endothelial ischemia-reperfusion injury in humans.

  2013cites this paper
• Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction.

  2013cites this paper
• Effects of tirofiban on the reperfusion-related no-reflow in rats with acute myocardial infarction

  2013cites this paper
• Suppression of NF-κB Reduces Myocardial No-Reflow

  2012cites this paper
• FOLLOW UP OF THE PATIENTS TREATED WITH THE MGUARD STENT SYSTEM IN PERCUTANEOUS CORONARY INTERVENTION (PCI) AT AFIC-NIHD

  2012cites this paper